share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股SEC公告 ·  09/26 16:18

Moomoo AI 已提取核心訊息

Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares on 09/26/2024, as per the latest filing. The shares, valued at an aggregate market value of $42,004.78, were originally acquired on the same date through options granted on 07/23/2018. The transaction will be conducted in cash. This sale follows a pattern of previous sales over the past three months, where a total of 18,000 shares were sold for gross proceeds of $137,475.60.
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares on 09/26/2024, as per the latest filing. The shares, valued at an aggregate market value of $42,004.78, were originally acquired on the same date through options granted on 07/23/2018. The transaction will be conducted in cash. This sale follows a pattern of previous sales over the past three months, where a total of 18,000 shares were sold for gross proceeds of $137,475.60.
Recursion Pharmaceuticals, Inc.高管Marriott Tina計劃於2024年09月26日出售6,000股A類股份,根據最新提交的文件。這些股票的總市值爲$42,004.78,最初是通過2018年07月23日授予的期權獲得的。交易將以現金方式進行。此次銷售跟隨在過去三個月內的先前銷售模式,共出售18,000股,總收入爲$137,475.60。
Recursion Pharmaceuticals, Inc.高管Marriott Tina計劃於2024年09月26日出售6,000股A類股份,根據最新提交的文件。這些股票的總市值爲$42,004.78,最初是通過2018年07月23日授予的期權獲得的。交易將以現金方式進行。此次銷售跟隨在過去三個月內的先前銷售模式,共出售18,000股,總收入爲$137,475.60。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息